Cosmos Health (NASDAQ:COSM) Trading Up 4.1% – Time to Buy?

Cosmos Health Inc. (NASDAQ:COSM)’s share price traded up 4.1% during trading on Monday . The stock traded as high as $0.3919 and last traded at $0.3854. 225,799 shares were traded during mid-day trading, a decline of 64% from the average session volume of 627,339 shares. The stock had previously closed at $0.3702.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Cosmos Health Stock Performance

The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The stock has a market capitalization of $13.70 million, a price-to-earnings ratio of -0.49 and a beta of 5.39. The firm’s fifty day moving average price is $0.45 and its 200 day moving average price is $0.67.

Insider Transactions at Cosmos Health

In other news, CEO Grigorios Siokas purchased 388,532 shares of the stock in a transaction dated Thursday, February 12th. The stock was acquired at an average cost of $0.37 per share, for a total transaction of $143,756.84. Following the completion of the transaction, the chief executive officer directly owned 8,861,914 shares in the company, valued at approximately $3,278,908.18. This represents a 4.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Insiders purchased a total of 2,401,929 shares of company stock valued at $1,096,186 over the last 90 days. 25.10% of the stock is owned by insiders.

Institutional Trading of Cosmos Health

Several hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC boosted its holdings in Cosmos Health by 260.5% in the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after purchasing an additional 241,775 shares during the period. Citadel Advisors LLC increased its holdings in Cosmos Health by 133.1% during the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares during the period. Finally, XTX Topco Ltd raised its position in Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares in the last quarter. 12.61% of the stock is currently owned by institutional investors and hedge funds.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.